ABBV
$ABBV
AbbVie Inc.
Biopharmaceutical company known for Humira, Skyrizi, and Rinvoq immunology drugs.
HealthcareSubscribers
1
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
ABBV: Pipeline strength vs. tariff and valuation risk
AbbVie ($ABBV) balances a strong dermatology pipeline and steady dividend with near-term risks from proposed drug tariffs and stretched trailing valuation. Analysts remain bullish, but key catalysts this quarter will determine direction.
Apr 6, 2026